666 results on '"Extracorporeal membrane oxygenation"'
Search Results
2. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline.
- Author
-
Sahetya, Sarina, Munshi, Laveena, Summers, Charlotte, Abrams, Darryl, Beitler, Jeremy, Bellani, Giacomo, Brower, Roy, Burry, Lisa, Chen, Jen-Ting, Hodgson, Carol, Hough, Catherine, Lamontagne, Francois, Law, Anica, Papazian, Laurent, Pham, Tai, Rubin, Eileen, Siuba, Matthew, Telias, Irene, Patolia, Setu, Chaudhuri, Dipayan, Walkey, Allan, Rochwerg, Bram, Fan, Eddy, and Qadir, Nida
- Subjects
acute respiratory distress syndrome ,corticosteroids ,extracorporeal membrane oxygenation ,neuromuscular blockade ,positive end-expiratory pressure ,Adult ,Humans ,Adrenal Cortex Hormones ,Lung ,Neuromuscular Blocking Agents ,Positive-Pressure Respiration ,Respiratory Distress Syndrome - Abstract
Background: This document updates previously published Clinical Practice Guidelines for the management of patients with acute respiratory distress syndrome (ARDS), incorporating new evidence addressing the use of corticosteroids, venovenous extracorporeal membrane oxygenation, neuromuscular blocking agents, and positive end-expiratory pressure (PEEP). Methods: We summarized evidence addressing four PICO questions (patient, intervention, comparison, and outcome). A multidisciplinary panel with expertise in ARDS used the Grading of Recommendations, Assessment, Development, and Evaluation framework to develop clinical recommendations. Results: We suggest the use of: 1) corticosteroids for patients with ARDS (conditional recommendation, moderate certainty of evidence), 2) venovenous extracorporeal membrane oxygenation in selected patients with severe ARDS (conditional recommendation, low certainty of evidence), 3) neuromuscular blockers in patients with early severe ARDS (conditional recommendation, low certainty of evidence), and 4) higher PEEP without lung recruitment maneuvers as opposed to lower PEEP in patients with moderate to severe ARDS (conditional recommendation, low to moderate certainty), and 5) we recommend against using prolonged lung recruitment maneuvers in patients with moderate to severe ARDS (strong recommendation, moderate certainty). Conclusions: We provide updated evidence-based recommendations for the management of ARDS. Individual patient and illness characteristics should be factored into clinical decision making and implementation of these recommendations while additional evidence is generated from much-needed clinical trials.
- Published
- 2024
3. Cardiac surgery during wartime in Israel.
- Author
-
Keizman, Eitan, Jamal, Tamer, Sarantsev, Irena, Ram, Eilon, Furman, Aryel, Kogan, Alexander, Raanani, Ehud, and Sternik, Leonid
- Subjects
- *
CARDIAC surgery , *EXTRACORPOREAL membrane oxygenation , *SURGICAL complications , *RECRUITING & enlistment (Armed Forces) , *MILITARY service - Abstract
Background: The war that began on October 7th, 2023, has impacted all major tertiary medical centers in Israel. In the largest cardiac surgery department in Israel there has been a surprising increase in the number of open-heart procedures, despite having approximately 50% of surgeons recruited to military service. The purpose of this study is to characterize this increase in the number of operations performed during wartime and assess whether the national crisis has affected patient outcomes. Methods: The study was based on a prospectively collected registry of 275 patients who underwent cardiac surgery or extracorporeal membrane oxygenation (ECMO) during the first two months of war, October 7th 2023 – December 7th 2023, as well as patients that underwent cardiac surgery during the same period of time in 2022 (October 7th, 2022 – December 7th, 2022). Results: 120 patients (43.6%) were operated on in 2022, and 155 (56.4%) during wartime in 2023. This signifies a 33.0% increase in open-heart procedures (109 in 2022 vs. 145 in 2023, p-value 0.26). There were no significant differences in the baseline characteristics of patients when comparing the 2022 patients to those in 2023. No significant differences between the two groups were found with regards to intraoperative characteristics or the type of surgery. However, compared to 2022, there was a 233% increase in the number of transplantations in the 2023 cohort (p-value 0.24). Patient outcomes during wartime were similar to those of 2022, including postoperative complications, length of stay, and mortality. Conclusions: Patients who underwent cardiac surgery during wartime presented with comparable outcomes when compared to those of last year despite the increase in cardiac surgery workload. There was an increase in the number of transplants this year, attributed to the unfortunate increase in organ donors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Pneumonectomy following penetrating trauma with ECMO as postoperative support: case report – (Lung trauma and ECMO).
- Author
-
Sánchez-Ortiz, Álvaro Ignacio, Peña-González, Diego, García, Alberto F., Bautista-Rincón, Diego Fernando, García-González, Carlos Alejandro, Moreno-Angarita, Alejandro, Álvarez-Ortega, Astrid Carolina, Torres-España, Nicolas Felipe, Cadavid-Alvear, Eduardo Alberto, and Velásquez-Galvis, Mauricio
- Subjects
- *
PENETRATING wounds , *PNEUMONECTOMY , *RIGHT ventricular dysfunction , *EXTRACORPOREAL membrane oxygenation , *LUNGS , *RESPIRATORY insufficiency , *HOSPITAL emergency services - Abstract
Background: Penetrating thoracic injuries have a significant risk of morbi-mortality. Despite the advancements in damage control methods, a subset of patients with severe pulmonary vascular lesions and bronchial injuries persists. In some of these cases, post-traumatic pneumonectomy is required, and perioperative extracorporeal membrane oxygenation (ECMO) support may be required due to right ventricular failure and respiratory failure. Case description: A male was brought to the emergency department (ED) with a penetrating thoracic injury, presenting with massive right hemothorax and active bleeding that required ligation of the right pulmonary hilum to control the bleeding. Subsequently, he developed right ventricular dysfunction and ARDS, necessitating a dynamic hybrid ECMO configuration to support his condition and facilitate recovery. Conclusions: Penetrating thoracic injuries with severe pulmonary vascular lesions may need pneumonectomy to control bleeding. ECMO support reduces the associated mortality by decreasing the complications rate. A multidisciplinary team is essential to achieve good outcomes in severe compromised patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Living-donor lobar lung transplantation for pulmonary Langerhans cell histiocytosis complicated by extensive thrombi in central pulmonary arteries.
- Author
-
Date, Naoki, Ohsumi, Akihiro, Minatoya, Kenji, and Date, Hiroshi
- Subjects
LANGERHANS-cell histiocytosis ,LUNG transplantation ,PULMONARY artery ,PULMONARY hypertension ,EXTRACORPOREAL membrane oxygenation ,LANGERHANS cells - Abstract
Background: Pulmonary Langerhans cell histiocytosis (PLCH) is a rare disorder characterized by the proliferation of Langerhans cells along the small airways, which causes nodular and cystic changes in the lung parenchyma. Lung transplantation can be a life-saving option for patients with severe respiratory failure or pulmonary hypertension. Herein, we present a case of successful lung transplantation in a patient with PLCH who developed unusually large thrombi in the central pulmonary artery. Case presentation: A 47-year-old woman with 16-year history of PLCH with rapidly developing respiratory failure was admitted to our hospital for the evaluation of a lung transplant. Enhanced computed tomography revealed large thrombi in dilated central pulmonary arteries. Right heart catheterization revealed severe pulmonary hypertension, with a mean pulmonary artery pressure of 48 mmHg. The thrombi shrank markedly after 3 months of anticoagulation therapy. However, the respiratory status of the patient did not improve. We performed bilateral living-donor lobar lung transplantation with thrombectomy under extracorporeal membrane oxygenation for the remaining thrombi in the main pulmonary arteries. The dilated main pulmonary arteries of the recipient required direct plication for size mismatch. The patient survived in good condition for more than 2 years with no recurrence of thrombosis. Conclusion: Preoperative anticoagulation therapy for massive thrombi in the pulmonary arteries was effective and led to safe lung transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Low Stroke Volume Predicts Deterioration in Intermediate-Risk Pulmonary Embolism: Prospective Study.
- Author
-
Weekes, Anthony J., Hambright, Parker, Trautmann, Ariana, Ali, Shane, Pikus, Angela, Wellinsky, Nicole, Shah, Sanjeev, and O’Connell, Nathaniel
- Subjects
- *
PULMONARY embolism , *ANTICOAGULANTS , *RISK assessment , *TRICUSPID valve , *PREDICTION models , *EXTRACORPOREAL membrane oxygenation , *HEMODYNAMICS , *HOSPITAL emergency services , *HEART physiology , *TREATMENT effectiveness , *DILATATION & curettage , *DESCRIPTIVE statistics , *LONGITUDINAL method , *ODDS ratio , *CLINICAL deterioration , *DOPPLER echocardiography , *STROKE volume (Cardiac output) , *COMPARATIVE studies , *RIGHT heart ventricle , *CARDIAC arrest , *CATECHOLAMINES , *REPERFUSION , *HYPOTENSION , *DISEASE risk factors , *DISEASE complications - Abstract
Introduction: Prognosis and management of patients with intermediate-risk pulmonary embolism (PE) is challenging. We investigated whether stroke volume may be used to identify the subset of this population at increased risk of clinical deterioration or PE-related death. Our secondary objective was to compare echocardiographic measurements of patients who received escalated interventions vs anticoagulation monotherapy. Methods: We selected patients with intermediate-risk PE, who had comprehensive echocardiography within 18 hours of PE diagnosis and before any escalated interventions, from a PE registry populated by 11 emergency departments. Echocardiographers measured right ventricle (RV) size, tricuspid annular plane systolic excursion (TAPSE), and stroke volume (SV) using velocity time integral (VTI) by left ventricular (LV) outflow tract Doppler or two-dimensional method of discs (MOD). The primary outcome was a composite of PE-related death, cardiac arrest, catecholamine administration for sustained hypotension, or emergency respiratory intervention during the index hospitalization. Secondary outcome was escalated intervention with reperfusion or extracorporeal membrane oxygenation therapy. Results: Of 370 intermediate-risk PE patients (mean age 64.0 ± 15.5 years, 38.1% male), 39 (10.5%) had the primary outcome. These 39 patients had lower mean SV regardless of measurement method than those without the primary outcome: SV MOD 36.2 vs 49.9 milliliters (mL), P < 0.001; SV Doppler 41.7 vs 57.2 mL, P = 0.003; VTI 13.6 vs 17.9 centimeters [cm], P = 0.003. Patients with primary outcome also had lower mean TAPSE than those without (1.54 vs 1.81 cm, P = 0.003). Multivariable models, selecting SV as predictor, had area under the receiver operating curve of 0.8 and Brier score 0.08. The best echocardiographic predictor of our primary outcome was SV MOD (odds ratio 0.72 [0.53, 0.94], P = 0.02). Patients who received escalated interventions had significantly lower SV or surrogate measurements, greater RV dilatation, and lower RV systolic function than patients who received anticoagulation monotherapy. Low stroke volume was a predictor of clinical deterioration and PE-related death. Low SV may be used to identify a subset of intermediate-risk PE patients, who are higher risk (intermediate-high risk), and for whom escalated interventions should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Extracorporeal Membrane Oxygenation after Pediatric Cardiac Surgery: A Single-Center Experience.
- Author
-
Botan, Edin, Aslan, Ayşen Durak, Gün, Emrah, Havan, Merve, Dikmen, Nur, Gurbanov, Anar, Balaban, Burak, Kahveci, Fevzi, Özen, Hasan, Uçmak, Hacer, Can, Özlem Selvi, Karagözlü, Selen, Sarıcaoğlu, Mehmet Cahit, Eyileten, Zeynep, Uçar, Tayfun, Tutar, Ercan, Akar, Ahmet Rüçhan, Uysalel, Mustafa Adnan, and Kendirli, Tanıl
- Subjects
- *
CONGENITAL heart disease , *PEDIATRIC surgery , *POSTOPERATIVE care , *HEART diseases , *THERAPEUTIC complications , *HYDROGEN-ion concentration , *EXTRACORPOREAL membrane oxygenation , *SURGERY , *PATIENTS , *SURVIVAL rate , *T-test (Statistics) , *FISHER exact test , *PULMONARY hypertension , *TREATMENT effectiveness , *RETROSPECTIVE studies , *TREATMENT duration , *DESCRIPTIVE statistics , *CHI-squared test , *MANN Whitney U Test , *PEDIATRICS , *ATRIAL septal defects , *CARDIAC output , *NEUROLOGICAL disorders , *KAPLAN-Meier estimator , *INTENSIVE care units , *LACTATES , *MEDICAL records , *ACQUISITION of data , *VENTRICULAR septal defects , *DATA analysis software , *CARDIOPULMONARY resuscitation , *COMPARATIVE studies , *CARDIAC surgery - Abstract
Objective: Extracorporeal membrane oxygenation (ECMO) is a life-saving treatment option providing cardiopulmonary support when standard therapies prove insufficient for reversible diseases. The mean objective of this study was to evaluate our center’s experience with ECMO following pediatric cardiac surgery. Materials and Methods: This retrospective study was conducted in our pediatric intensive care unit (PICU) between November 2014 and March 2021 and included patients who received ECMO following cardiac surgery. Results: Over the 7-year period, 324 patients underwent cardiac surgery, of which 24 (7.4%) required ECMO support. Among them, 13 (54.2%) were female, with a median age of 16.0 (2.0-208) months and a median weight of 7.0 (3.5-70) kg. The mean vasoactive inotrope score (VIS) was 53.9 ± 44.5. Atrioventricular septal defect repair was the most common surgical procedure (n = 8/24, 41.6%). The primary indication for ECMO was low cardiac output syndrome (LCOS) in 14 (58.3%) patients. The median duration of ECMO support was 6.0 (1.0-46.0) days. Nonsurvivors had significantly higher Pediatric Risk Score of Mortality (PRISM) III scores (P = .014) and VIS scores during the pre-ECMO period (P = .004). Early or late neurological complications developed in 12 (50%) patients, with significant differences in lactate levels and pH levels pre-ECMO between those with and without neurological complications (P = .01, P = .02, respectively). We successfully decannulated 16 (66.6%) patients, with a final survival rate of 12 (50%). Conclusion: ECMO plays a crucial role in providing pre- and post-cardiac surgery support for children. LCOS remains the main indication, and high PRISM III and VIS scores are valuable predictors of outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Upper gastrointestinal bleeding on veno-arterial extracorporeal membrane oxygenation support.
- Author
-
de Roux, Quentin, Disli, Yekcan, Bougouin, Wulfran, Renaudier, Marie, Jendoubi, Ali, Merle, Jean-Claude, Delage, Mathilde, Picard, Lucile, Sayagh, Faiza, Cherait, Chamsedine, Folliguet, Thierry, Quesnel, Christophe, Becq, Aymeric, and Mongardon, Nicolas
- Subjects
- *
RISK assessment , *GASTROINTESTINAL hemorrhage , *EXTRACORPOREAL membrane oxygenation , *PEPTIC ulcer , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *CHI-squared test , *MANN Whitney U Test , *MULTIVARIATE analysis , *ODDS ratio , *MEDICAL records , *ACQUISITION of data , *COMPARATIVE studies , *CONFIDENCE intervals , *LENGTH of stay in hospitals , *DATA analysis software , *DISEASE risk factors - Abstract
Introduction: Patients on veno-arterial extracorporeal membrane oxygenation (V-A ECMO) support are at a high risk of hemorrhagic complications, including upper gastrointestinal bleeding (UGIB). The objective of this study was to evaluate the incidence and impact of this complication in V-A ECMO patients. Materials and methods: A retrospective single-center study (2013–2017) was conducted on V-A ECMO patients, excluding those who died within 24 h. All patients with suspected UGIB underwent esophagogastroduodenoscopy (EGD) and were analyzed and compared to the remainder of the cohort, from the initiation of ECMO until 5 days after explantation. Results: A total of 150 V-A ECMO cases (65 after cardiac surgery and 85 due to medical etiology) were included. 90% of the patients received prophylactic proton pump inhibitor therapy and enteral nutrition. Thirty-one patients underwent EGD for suspected UGIB, with 16 confirmed cases of UGIB. The incidence was 10.7%, with a median occurrence at 10 [7–17] days. There were no significant differences in clinical or biological characteristics on the day of EGD. However, patients with UGIB had significant increases in packed red blood cells and fresh frozen plasma needs, mechanical ventilation duration and V-A ECMO duration, as well as in length of intensive care unit and hospital stays. There was no significant difference in mortality. The only independent risk factor of UGIB was a history of peptic ulcer (OR = 7.32; 95% CI [1.07–50.01], p = 0.042). Conclusion: UGIB occurred in at least 1 out of 10 cases of V-A ECMO patients, with significant consequences on healthcare resources. Enteral nutrition and proton pump inhibitor prophylaxis did not appear to protect V-A ECMO patients. Further studies should assess their real benefits in these patients with high risk of hemorrhage. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Long-term outcomes following mitral valve replacement in children at heart center Leipzig: a 20-year analysis.
- Author
-
Schumacher, Katja, Marin-Cuartas, Mateo, Aydin, Muhammed Ikbal, de la Cuesta, Manuela, Meier, Sabine, Borger, Michael Andrew, Dähnert, Ingo, Kostelka, Martin, and Vollroth, Marcel
- Subjects
- *
MITRAL valve , *EXTRACORPOREAL membrane oxygenation , *CHILD patients , *MITRAL valve surgery , *HOSPITAL mortality - Abstract
Background: Although mitral valve repair is the preferred surgical strategy in children with mitral valve disease, there are cases of irreparable severe dysplastic valves that require mitral valve replacement. The aim of this study is to analyze long-term outcomes following mitral valve replacement in children in a tertiary referral center. Methods: A total of 41 consecutive patients underwent mitral valve replacement between February 2001 and February 2021. The study data was prospectively collected and retrospectively analyzed. Primary outcomes were in-hospital mortality, long-term survival, and long-term freedom from reoperation. Results: Median age at operation was 23 months (IQR 5–93), median weight was 11.3 kg (IQR 4.8–19.4 kg). One (2.4%) patient died within the first 30 postoperative days. In-hospital mortality was 4.9%. Four (9.8%) patients required re-exploration for bleeding, and 2 (4.9%) patients needed extracorporeal life support. Median follow-up was 11 years (IQR 11 months − 16 years). Long-term freedom from re-operation after 1, 5, 10 and 15 years was 97.1%, 93.7%, 61.8% and 42.5%, respectively. Long-term survival after 1, 5, 10 and 15 years was 89.9%, 87%, 87% and 80.8%, respectively. Conclusion: If MV repair is not feasible, MV replacement offers a good surgical alternative for pediatric patients with MV disease. It provides good early- and long-term outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Why left atrial venting fails to influence extracorporeal life support survival in cardiogenic shock: Unravelling the intricate reality of unloading.
- Author
-
Ughetto, Aurore, Vandenbriele, Christophe, and Delmas, Clément
- Subjects
- *
CARDIOGENIC shock , *INTRA-aortic balloon counterpulsation , *LEFT heart atrium , *EXTRACORPOREAL membrane oxygenation , *LOADING & unloading , *ARTIFICIAL blood circulation , *CORONARY care units , *ATRIAL septum - Abstract
The article discusses the use of left atrial venting as a technique to unload the left ventricle in patients with cardiogenic shock undergoing extracorporeal life support (ECLS). Two recent trials, EARLY-UNLOAD and EVOLVE-ECMO, found no significant differences in 30-day mortality rates between early unloading through active left atrial venting and a rescue unloading strategy. The article acknowledges the challenges of interpreting the results due to sample size limitations and the complexity of intention-to-treat analysis. The authors suggest that further investigation is needed to determine the effectiveness and timing of left heart decompression techniques. The text also provides an overview of past and present mechanical circulatory support unloading trials in cardiogenic shock, highlighting the ongoing REMAP-ECMO and UNLOAD-ECMO trials that aim to determine the optimal timing of left heart decompression initiation. The article emphasizes the need for further research comparing different devices and timing of left heart decompression initiation, and suggests that decisions should be made on a case-by-case basis guided by local expertise and available strategies. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
11. Algorithm for airway management in benign intratracheal lesions.
- Author
-
EL HADI, NADINE, HOSRI, JAD, TULIMAT, TAMAM, and HADI, USAMAH
- Subjects
- *
AIRWAY (Anatomy) , *EXTRACORPOREAL membrane oxygenation , *CARDIOPULMONARY bypass , *ALGORITHMS - Abstract
The authors have conducted a retrospective analysis based on two cases of patients with intra-tracheal pathologies who received treatment from the same surgeon at a tertiary referral center. The effective management of airways in patients with intra-tracheal lesions necessitates close collaboration between surgeons and anesthesiologists. Factors such as the size, location, rigidity of the tumor, and the remaining tracheal lumen space should be carefully considered. In situations where there is near complete obstruction of the trachea and a substantial risk of worsened respiratory function, resorting to cardiopulmonary bypass or extracorporeal membrane oxygenation is advisable. This pilot study aims at devising an algorithm for the airway management of intra-tracheal lesions, although a larger case cohort is needed to assess its applicability and effectiveness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Cardiogenic Shock: An Overview.
- Author
-
Toufic El Hussein, Mohamed and Mushaluk, Camila
- Subjects
CARDIOGENIC shock ,RISK assessment ,EXTRACORPOREAL membrane oxygenation ,CARDIOTONIC agents ,HEART assist devices ,INTRA-aortic balloon counterpulsation ,HOSPITAL mortality ,CARDIAC output ,EVIDENCE-based medicine ,VASOCONSTRICTORS ,ARTIFICIAL blood circulation ,DOBUTAMINE ,MILRINONE ,DISEASE risk factors ,SYMPTOMS - Abstract
Cardiogenic shock (CS) is a complex and dreadful condition for which effective treatments remain unclear. The concerningly high mortality rate of CS emphasizes a need for developing effective therapies to reduce its mortality and reverse its detrimental course. This article aims to provide an updated and evidence-based review of the pathophysiology of CS and the related pharmacotherapeutics with a special focus on vasoactive and inotropic agents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. A Qualitative Study to Explore the Nurses' Experience of Writing Caring Notes in Diaries for Extracorporeal Oxygenation Membrane (ECMO) Patients: Explore the nurse's experience.
- Author
-
Norton, Tamara, Chechel, Laura, Sanchez, Courtney, and Terterian, Garni
- Subjects
EMPATHY ,EXTRACORPOREAL membrane oxygenation ,CRITICALLY ill ,PATIENTS ,QUALITATIVE research ,ACADEMIC medical centers ,HUMANITY ,HOSPITAL nursing staff ,INTERVIEWING ,QUESTIONNAIRES ,WORK experience (Employment) ,JUDGMENT sampling ,DESCRIPTIVE statistics ,THEMATIC analysis ,SOUND recordings ,NURSES' attitudes ,DIARY (Literary form) ,INTENSIVE care units ,RESEARCH methodology ,LENGTH of stay in hospitals ,PHENOMENOLOGY ,SOCIAL support ,FAMILY support ,CRITICAL care nurses ,WRITTEN communication - Abstract
The use of diaries is known to reduce post-intensive care syndrome in the intensive care unit (ICU) for survivors and families. Studies are needed to explore nurses' experience with diaries. Although the diaries are written for the patient, the diary entries may be helpful for the nurse as well. Research has shown that ICU diaries fill in significant memory gaps and aid in the resolution of delusional memories. However, there is a shortage of knowledge about the nurses' experience of writing caring notes in diaries. The purpose of this research was to explore the extracorporeal membrane oxygenation (ECMO) nurses' experience of writing caring notes in diaries during the patients' ICU stay. This is a descriptive phenomenological qualitative research study using semi-structured interviews. A one-on-one interview was performed, audiotaped, and transcribed. Three investigators analyzed the data for themes, subcategories, and indicators. A purposive sample of 15 specialty-trained ECMO nurses participated in the study. Three themes emerged from the study relating to the nurse, family, and patient, including positive and negative aspects of writing in the diary and barriers. The vast majority (88%) of 340 comments answered during the interviews were positive. Overall, nurses found the diaries to be beneficial to the nurse, family, and patient. Diary writing may help nurses get back to the core of why we do what they do. Understanding the nurses' experience may help to improve communication and family satisfaction while optimizing dairy programs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
- Author
-
de Prost, Nicolas, Audureau, Etienne, Guillon, Antoine, Handala, Lynda, Préau, Sébastien, Guigon, Aurélie, Uhel, Fabrice, Le Hingrat, Quentin, Delamaire, Flora, Grolhier, Claire, Tamion, Fabienne, Moisan, Alice, Darreau, Cédric, Thomin, Jean, Contou, Damien, Henry, Amandine, Daix, Thomas, Hantz, Sébastien, Saccheri, Clément, and Giordanengo, Valérie
- Subjects
- *
THERAPEUTIC use of monoclonal antibodies , *CRITICALLY ill , *PATIENTS , *EXTRACORPOREAL membrane oxygenation , *RESEARCH funding , *MULTIPLE regression analysis , *FISHER exact test , *KRUSKAL-Wallis Test , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *CHI-squared test , *REVERSE transcriptase polymerase chain reaction , *LONGITUDINAL method , *ODDS ratio , *RESEARCH , *INTENSIVE care units , *ARTIFICIAL respiration , *STATISTICS , *ANALYSIS of variance , *GENETIC mutation , *CONFIDENCE intervals , *DATA analysis software , *COVID-19 , *SARS-CoV-2 , *PHENOTYPES , *COVID-19 pandemic , *OBESITY , *IMMUNOSUPPRESSION - Abstract
Background: A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However, no clinical data are available regarding critically-ill JN.1 COVID-19 infected patients. Methods: The current study is a substudy of the SEVARVIR prospective multicenter observational cohort study. Patients admitted to any of the 40 participating ICUs between November 17, 2022, and January 22, 2024, were eligible for inclusion in the SEVARVIR cohort study (NCT05162508) if they met the following inclusion criteria: age ≥ 18 years, SARS-CoV-2 infection confirmed by a positive reverse transcriptase-polymerase chain reaction (RT-PCR) in nasopharyngeal swab samples, ICU admission for acute respiratory failure. The primary clinical endpoint of the study was day-28 mortality. Evaluation of the association between day-28 mortality and sublineage group was conducted by performing an exploratory multivariable logistic regression model, after systematically adjusting for predefined prognostic factors previously shown to be important confounders (i.e. obesity, immunosuppression, age and SOFA score) computing odds ratios (OR) along with their corresponding 95% confidence intervals (95% CI). Results: During the study period (November 2022–January 2024) 56 JN.1- and 126 XBB-infected patients were prospectively enrolled in 40 French intensive care units. JN.1-infected patients were more likely to be obese (35.7% vs 20.8%; p = 0.033) and less frequently immunosuppressed than others (20.4% vs 41.4%; p = 0.010). JN.1-infected patients required invasive mechanical ventilation support in 29.1%, 87.5% of them received dexamethasone, 14.5% tocilizumab and none received monoclonal antibodies. Only one JN-1 infected patient (1.8%) required extracorporeal membrane oxygenation support during ICU stay (vs 0/126 in the XBB group; p = 0.30). Day-28 mortality of JN.1-infected patients was 14.6%, not significantly different from that of XBB-infected patients (22.0%; p = 0.28). In univariable logistic regression analysis and in multivariable analysis adjusting for confounders defined a priori, we found no statistically significant association between JN.1 infection and day-28 mortality (adjusted OR 1.06 95% CI (0.17;1.42); p = 0.19). There was no significant between group difference regarding duration of stay in the ICU (6.0 [3.5;11.0] vs 7.0 [4.0;14.0] days; p = 0.21). Conclusions: Critically-ill patients with Omicron JN.1 infection showed a different clinical phenotype than patients infected with the earlier XBB sublineage, including more frequent obesity and less immunosuppression. Compared with XBB, JN.1 infection was not associated with higher day-28 mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. ECMO is associated with decreased hospital mortality in COVID-19 ARDS.
- Author
-
Kim, Won-Young, Jung, Sun-Young, Kim, Jeong-Yeon, Chae, Ganghee, Kim, Junghyun, Joh, Joon-Sung, Park, Tae Yun, Baek, Ae-Rin, Jegal, Yangjin, Chung, Chi Ryang, Lee, Jinwoo, Cho, Young-Jae, Park, Joo Hun, Hwang, Jung Hwa, and Song, Jin Woo
- Subjects
- *
HOSPITAL mortality , *COVID-19 , *ADULT respiratory distress syndrome , *EXTRACORPOREAL membrane oxygenation , *PATIENT positioning - Abstract
This study determined whether compared to conventional mechanical ventilation (MV), extracorporeal membrane oxygenation (ECMO) is associated with decreased hospital mortality or fibrotic changes in patients with COVID-19 acute respiratory distress syndrome. A cohort of 72 patients treated with ECMO and 390 with conventional MV were analyzed (February 2020–December 2021). A target trial was emulated comparing the treatment strategies of initiating ECMO vs no ECMO within 7 days of MV in patients with a PaO2/FiO2 < 80 or a PaCO2 ≥ 60 mmHg. A total of 222 patients met the eligibility criteria for the emulated trial, among whom 42 initiated ECMO. ECMO was associated with a lower risk of hospital mortality (hazard ratio [HR], 0.56; 95% confidence interval [CI] 0.36–0.96). The risk was lower in patients who were younger (age < 70 years), had less comorbidities (Charlson comorbidity index < 2), underwent prone positioning before ECMO, and had driving pressures ≥ 15 cmH2O at inclusion. Furthermore, ECMO was associated with a lower risk of fibrotic changes (HR, 0.30; 95% CI 0.11–0.70). However, the finding was limited due to relatively small number of patients and differences in observability between the ECMO and conventional MV groups. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Hemodynamics with mechanical circulatory support devices using a cardiogenic shock model.
- Author
-
Yahagi, Kazuyuki, Nishimura, Gohki, Kuramoto, Kei, Tsuboko, Yusuke, and Iwasaki, Kiyotaka
- Subjects
- *
HEART assist devices , *CARDIOGENIC shock , *HEMODYNAMICS , *ARTIFICIAL blood circulation , *VENTILATION , *EXTRACORPOREAL membrane oxygenation , *PULSATILE flow - Abstract
Mechanical circulatory support (MCS) devices, including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella, have been widely used for patients with cardiogenic shock (CS). However, hemodynamics with each device and combination therapy is not thoroughly understood. We aimed to elucidate the hemodynamics with MCS using a pulsatile flow model. Hemodynamics with Impella CP, VA-ECMO, and a combination of Impella CP and VA-ECMO were assessed based on the pressure and flow under support with each device and the pressure–volume loop of the ventricle model. The Impella CP device with CS status resulted in an increase in aortic pressure and a decrease in end-diastolic volume and end-diastolic pressure (EDP). VA-ECMO support resulted in increased afterload, leading to a significant increase in aortic pressure with an increase in end-systolic volume and EDP and decreasing venous reservoir pressure. The combination of Impella CP and VA-ECMO led to left ventricular unloading, regardless of increase in afterload. Hemodynamic support with Impella and VA-ECMO should be a promising combination for patients with severe CS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause Inpatient Mortality Rate.
- Author
-
Movahed, Mohammad Reza, Soltani Moghadam, Arman, and Hashemzadeh, Mehrtash
- Subjects
- *
CARDIOGENIC shock , *HEART failure , *ST elevation myocardial infarction , *MYOCARDIAL infarction , *DEATH rate , *MORTALITY , *EXTRACORPOREAL membrane oxygenation , *PERIPHERAL vascular diseases , *INTRA-aortic balloon counterpulsation - Abstract
Background: The goal of this study was to evaluate the effect of extracorporeal membrane oxygenation (ECMO) on mortality in patients with cardiogenic shock excluding Impella and IABP use. Method: The large Nationwide Inpatient Sample (NIS) database was utilized to study any association between the use of ECMO in adults over the age of 18 and mortality and complications with a diagnosis of cardiogenic shocks. Results: ICD-10 codes for ECMO and cardiogenic shock for the available years 2016–2020 were utilized. A total of 796,585 (age 66.5 ± 14.4) patients had a diagnosis of cardiogenic shock excluding Impella. Of these patients, 13,160 (age 53.7 ± 15.4) were treated with ECMO without IABP use. Total inpatient mortality without any device was 32.7%. It was 47.9% with ECMO. In a multivariate analysis adjusting for 47 variables such as age, gender, race, lactic acidosis, three-vessel intervention, left main myocardial infarction, cardiomyopathy, systolic heart failure, acute ST-elevation myocardial infarction, peripheral vascular disease, chronic renal disease, etc., ECMO utilization remained highly associated with mortality (OR: 1.78, CI: 1.6–1.9, p < 0.001). Evaluating teaching hospitals only revealed similar findings. Major complications were also high in the ECMO cohort. Conclusions: In patients with cardiogenic shock, the use of ECMO was associated with the high in-hospital mortality regardless of comorbid condition, high-risk futures, or type of hospital. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Antimicrobial Pharmacokinetic Considerations in Extracorporeal Membrane Oxygenation.
- Author
-
Johns, Kevin, Eschenauer, Gregory, Clark, Angela, Butler, Simona, and Dunham, Sabrina
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *MEDICAL personnel , *DRUG monitoring , *PHARMACOKINETICS , *PATIENT experience - Abstract
Critical illness creates challenges for healthcare providers in determining the optimal treatment of severe disease, particularly in determining the most appropriate selection and dosing of medications. Critically ill patients experience endogenous physiologic changes that alter the pharmacokinetics (PKs) of medications. These alterations can be further compounded by mechanical support modalities such as extracorporeal membrane oxygenation (ECMO). Specific components of the ECMO circuit have the potential to affect drug PKs through drug sequestration and an increase in the volume of distribution. Factors related to the medications themselves also play a role. These PK alterations create problems when trying to properly utilize antimicrobials in this patient population. The literature seeking to identify appropriate antimicrobial dosing regimens is both limited and difficult to evaluate due to patient variability and an inability to determine the exact role of the ECMO circuit in reduced drug concentrations. Lipophilic and highly protein bound medications are considered more likely to undergo significant drug sequestration in an ECMO circuit, and this general trend represents a logical starting point in antimicrobial selection and dosing in patients on ECMO support. This should not be the only consideration, however, as identifying infection and evaluating the efficacy of treatments in this population is challenging. Due to these challenges, therapeutic drug monitoring should be utilized whenever possible, particularly in cases with severe infection or high concern for drug toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center.
- Author
-
Sales, Gabriele, Montrucchio, Giorgia, Sanna, Valentina, Collino, Francesca, Fanelli, Vito, Filippini, Claudia, Simonetti, Umberto, Bonetto, Chiara, Morscio, Monica, Verderosa, Ivo, Urbino, Rosario, and Brazzi, Luca
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *INTENSIVE care units , *HOSPITAL mortality , *PROGNOSIS , *ADULT respiratory distress syndrome - Abstract
Background: The efficacy of veno-venous extracorporeal membrane oxygenation (VV-ECMO) as rescue therapy for refractory COVID-19-related ARDS (C-ARDS) is still debated. We describe the cohort of C-ARDS patients treated with VV-ECMO at our ECMO center, focusing on factors that may affect in-hospital mortality and describing the time course of lung mechanics to assess prognosis. Methods: We performed a prospective observational study in the intensive care unit at the "Città della Salute e della Scienza" University Hospital in Turin, Italy, between March 2020 and December 2021. Indications and management of ECMO followed the Extracorporeal Life Support Organization (ELSO) guidelines. Results: The 60-day in-hospital mortality was particularly high (85.4%). Non-survivor patients were more frequently treated with non-invasive ventilatory support and steroids before ECMO (95.1% vs. 57.1%, p = 0.018 and 73.2% vs. 28.6%, p = 0.033, respectively), while hypertension was the only pre-ECMO factor independently associated with in-hospital mortality (HR: 2.06, 95%CI: 1.06–4.00). High rates of bleeding (85.4%) and superinfections (91.7%) were recorded during ECMO, likely affecting the overall length of ECMO (18 days, IQR: 10–24) and the hospital stay (32 days, IQR: 24–47). Static lung compliance was lower in non-survivors (p = 0.031) and differed over time (p = 0.049), decreasing by 48% compared to initial values in non-survivors. Conclusions: Our data suggest the importance of considering NIS among the common ECMO eligibility criteria and changes in lung compliance during ECMO as a prognostic marker. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care.
- Author
-
Goeijenbier, M., van der Bie, S., Souverein, D., Bolluyt, D., Nagel, M., Stoof, S. P., Vermin, B., Weenink, J., van Gorp, E. C. M., Euser, S., Kalpoe, J., van Houten, M. A., Endeman, H., Gommers, D., Haas, L. E. M., and van Lelyveld, S. F. L.
- Subjects
- *
MYCOPLASMA pneumoniae infections , *MYCOPLASMA pneumoniae , *CRITICAL care medicine , *COVID-19 pandemic , *EXTRACORPOREAL membrane oxygenation , *BETA lactam antibiotics - Abstract
Background: Mycoplasma pneumoniae (M. pneumoniae) infections can progress to severe respiratory complications, necessitating intensive care treatment. Recent post COVID-19 pandemic surges underscore the need for timely diagnosis, given potential diagnostic method limitations. Methods: A retrospective case series analysis was conducted on M. pneumonia PCR-positive patients admitted to two Dutch secondary hospitals' ICUs between January 2023 and February 2024. Clinical presentations, treatments, outcomes, and mechanical ventilation data were assessed. Results: Seventeen ICU-admitted patients were identified, with a median age of 44 years, primarily due to hypoxia. Non-invasive ventilation was effective for most, while five required invasive mechanical ventilation. None of the patients required extracorporeal membrane oxygenation. No fatalities occurred. Post-PCR, treatment was adjusted to doxycycline or azithromycin; seven received steroid treatment. Discussion: Increased ICU admissions for M. pneumoniae infection were observed. Diverse clinical and radiological findings emphasize heightened clinical awareness. Early molecular diagnostics and tailored antibiotic regimens are crucial since beta-lactam antibiotics are ineffective. Conclusion: This study highlights the escalating challenge of severe M. pneumoniae infections in ICUs, necessitating a multifaceted approach involving accurate diagnostics, vigilant monitoring, and adaptable treatment strategies for optimal patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. New Insights into Hepatic and Intestinal Microcirculation and Pulmonary Inflammation in a Model of Septic Shock and Venovenous Extracorporeal Membrane Oxygenation in the Rat.
- Author
-
Edinger, Fabian, Zajonz, Thomas, Holtz, Lena, Schmidt, Götz, Schneck, Emmanuel, Sander, Michael, and Koch, Christian
- Subjects
- *
SEPTIC shock , *EXTRACORPOREAL membrane oxygenation , *TUMOR necrosis factors , *LABORATORY rats , *CARDIAC output - Abstract
Treatment of critically ill patients with venovenous (V-V) extracorporeal membrane oxygenation (ECMO) has gained wide acceptance in the last few decades. However, the use of V-V ECMO in septic shock remains controversial. The effect of ECMO-induced inflammation on the microcirculation of the intestine, liver, and critically damaged lungs is unknown. Therefore, the aim of this study was to measure the hepatic and intestinal microcirculation and pulmonary inflammatory response in a model of V-V ECMO and septic shock in the rat. Twenty male Lewis rats were randomly assigned to receive V-V ECMO therapy or a sham procedure. Hemodynamic data were measured by a pressure-volume catheter in the left ventricle and a catheter in the lateral tail artery. Septic shock was induced by the intravenous infusion of lipopolysaccharide (1 mg/kg). During V-V ECMO therapy, rats received lung-protective ventilation. The hepatic and intestinal microcirculation was assessed by micro-lightguide spectrophotometry after median laparotomy for 2 h. Systemic and pulmonary inflammation was measured by enzyme-linked immunosorbent assays of plasma and bronchoalveolar lavage (BAL), respectively, which included tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), IL-10, C-X-C motif ligand 2 (CXCL2), and CXCL5. Reduced oxygen saturation and relative hemoglobin concentration were measured in the hepatic and intestinal microcirculation during treatment with V-V ECMO. These animals also showed increased systolic, mean, and diastolic blood pressures. While no differences in left ventricular ejection fraction were observed, animals in the V-V ECMO group presented an increased heart rate, stroke volume, and cardiac output. Blood gas analysis showed dilutional anemia during V-V ECMO, whereas plasma analysis revealed a decreased concentration of IL-10 during V-V ECMO therapy, and BAL measurements showed increased concentrations of TNF-α, CXCL2, and CXCL5. Rats treated with V-V ECMO showed impaired microcirculation of the intestine and liver during septic shock despite increased blood pressure and cardiac output. Despite lung-protective ventilation, increased pulmonary inflammation was recognized during V-V ECMO therapy in septic shock. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Implementing enhanced extracorporeal membrane oxygenation for CPR (ECPR) in the emergency department.
- Author
-
Oliver, Matthew, Coggins, Andrew, Kruit, Natalie, Burns, Brian, Plunkett, Brian, Morgan, Steve, Southwood, Tim J., Totaro, Richard, Forrest, Paul, Russell, Saartje Berendsen, Carey, Ruaidhri, and Dennis, Mark
- Subjects
- *
NEUROLOGIC examination , *PATIENT selection , *EXTRACORPOREAL membrane oxygenation , *SURVIVAL rate , *HOSPITAL admission & discharge , *EMERGENCY medical services , *TREATMENT duration , *HOSPITAL mortality , *CARDIAC arrest , *CARDIOPULMONARY resuscitation - Abstract
Refractory out-of-hospital cardiac arrest (OHCA) has a very poor prognosis, with survival rates at around 10%. Extracorporeal membrane oxygenation (ECMO) for patients in refractory arrest, known as ECPR, aims to provide perfusion to the patient whilst the underlying cause of arrest can be addressed. ECPR use has increased substantially, with varying survival rates to hospital discharge. The best outcomes for ECPR occur when the time from cardiac arrest to implementation of ECPR is minimised. To reduce this time, systems must be in place to identify the correct patient, expedite transfer to hospital, facilitate rapid cannulation and ECMO circuit flows. We describe the process of activation of ECPR, patient selection, and the steps that emergency department clinicians can utilise to facilitate timely cannulation to ensure the best outcomes for patients in refractory cardiac arrest. With these processes in place our survival to hospital discharge for OHCA patients is 35%, with most patients having a good neurological function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Outcomes of Lung Transplantation in Patients With Right Ventricular Dysfunction: A Single-Center Retrospective Analysis Comparing ECMO Configurations in a Bridge-to-Transplant Setting.
- Author
-
Su Yeon Lee, Jee Hwan Ahn, Ho Cheol Kim, Tae Sun Shim, Pil-Je Kang, Geun Dong Lee, Se Hoon Choi, Sung-Ho Jung, Seung-Il Park, and Sang-Bum Hong
- Subjects
- *
RIGHT ventricular dysfunction , *LUNG transplantation , *HEART assist devices , *EXTRACORPOREAL membrane oxygenation , *LACTIC acid , *RETROSPECTIVE studies - Abstract
This study aimed to assess the lung transplantation (LT) outcomes of patients with right ventricular dysfunction (RVD), focusing on the impact of various extracorporeal membrane oxygenation (ECMO) configurations. We included adult patients who underwent LT with ECMO as a bridge-to-transplant from 2011 to 2021 at a single center. Among patients with RVD (n = 67), veno-venous (V-V) ECMO was initially applied in 79% (53/67) and maintained until LT in 52% (35/67). Due to the worsening of RVD, the configuration was changed from V-V ECMO to veno-arterial (V-A) ECMO or a right ventricular assist device with an oxygenator (Oxy-RVAD) in 34% (18/67). They showed that lactic acid levels (2-6.1 mmol/L) and vasoactive inotropic score (6.6-22.6) increased. V-A ECMO or Oxy-RVAD was initiated and maintained until LT in 21% (14/67) of cases. There was no significant difference in the survival rates among the three configuration groups (V-V ECMO vs. configuration changed vs. V-A ECMO/Oxy-RVAD). Our findings suggest that the choice of ECMOconfiguration for LT candidates with RVD should be determined by the patient's current hemodynamic status. Vital sign stability supports the use of V-V ECMO, while increasing lactic acid levels and vasopressor needs may require a switch to V-A ECMO or Oxy-RVAD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Importance of Echocardiography in Patients Supported by Extracorporeal Membrane Oxygenation.
- Author
-
Kudsioğlu, Türkan
- Abstract
ECMO is a mechanical support system applied in cases of severe heart and/or lung failure unresponsive to all treatments. The use of ECMO is increasing. Technological advancements in ECMO systems (oxygenator, pump, cannula systems, and cannulation techniques), careful patient selection, and the use of echocardiography (ECHO) contribute to improving survival rates. Additionally, the establishment of ECMO teams and increased experience in this field have also enhanced its applications. Knowledge of ECMO indications and contraindications, technical and intraoperative anesthesia management, and potential complications necessitates collaborative implementation in the operating room, intensive care unit, or during the e-CPR process. This review emphasizes the importance and guidance of transthoracic and transesophageal echocardiography (TTE and TEE) in peripheral or central ECMO applications, including ECMO cannulation, hemodynamic monitoring, and separation processes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Predictors of complicated influenza infection in children presenting in a tertiary hospital in a tropical country: A case-control study.
- Author
-
Chowdhury, Sudipta Roy, Nadua, Karen Donceras, Jiahui Li, Kai-Qian Kam, Koh Cheng Thoon, Woon Hui Tan, Natalie, Chee Fu Yung, and Chia Yin Chong
- Subjects
- *
INFLUENZA , *H7N9 Influenza , *CASE-control method , *EXTRACORPOREAL membrane oxygenation , *INFECTION - Abstract
This article examines the risk factors for severe influenza in children, specifically focusing on a study conducted in a tropical country. The study found that young age (<5 years) and the presence of comorbidities were associated with complicated influenza. Other factors such as abnormal vital signs, bacterial coinfections, and neurological conditions also increased the risk. The study highlights the importance of identifying these risk factors to better manage and prevent severe influenza in children. However, the study had limitations, including a lack of data on influenza vaccination status and inconsistent recording of height measurements. The authors concluded that influenza infection can lead to severe complications and mortality, particularly in patients with neurological symptoms, and emphasized the importance of vigilant care for these patients. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
26. Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.
- Author
-
Kriegl, Lisa, Hatzl, Stefan, Schilcher, Gernot, Zollner-Schwetz, Ines, Boyer, Johannes, Geiger, Christina, Hoenigl, Martin, and Krause, Robert
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *ANTIFUNGAL agents , *AMPHOTERICIN B , *CRITICAL care medicine , *MYCOSES - Abstract
Extracorporeal membrane oxygenation (ECMO) is a life-saving technique used in critical care medicine for patients with severe respiratory or cardiac failure. This review examines the treatment and prophylaxis of fungal infections in ECMO patients, proposing specific regimens based on available data for different antifungals (azoles, echinocandins, amphotericin B/liposomal amphotericin B) and invasive fungal infections. Currently, isavuconazole and posaconazole have the most supported data, while modified dosages of isavuconazole are recommended in ECMO. Echinocandins are preferred for invasive candidiasis. However, choosing echinocandins is challenging due to limited and varied data on concentration loss in the ECMO circuit. Caution is likewise advised when using liposomal amphotericin B due to uncertain concentrations and potential ECMO dysfunction based on scarce data. We further conclude with the importance of further research on the impact of ECMO on antifungal drug concentrations to optimize dosing regimens in critically ill patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Intra-operative Risk Factors Affecting Mortality after Heart Transplantation: A Referral Center Experience in Iran.
- Author
-
Tabaei, Ali Sadeghpour and Hashemi, Parham
- Subjects
- *
RISK assessment , *ELECTRIC countershock , *STATISTICAL correlation , *PATIENTS , *TRANSPLANTATION of organs, tissues, etc. , *EXTRACORPOREAL membrane oxygenation , *PATIENT readmissions , *LOGISTIC regression analysis , *RETROSPECTIVE studies , *HEART transplantation , *SURGICAL complications , *LONGITUDINAL method , *ODDS ratio , *KAPLAN-Meier estimator , *REOPERATION , *STATISTICS , *SURVIVAL analysis (Biometry) , *DATA analysis software , *CONFIDENCE intervals , *DISEASE complications ,MORTALITY risk factors - Abstract
Background: Heart transplantation is the preferred treatment for end-stage heart failure. This study investigated the intraoperative risk factors affecting post-transplantation mortality. Methods: This single-center retrospective cohort study examined 239 heart transplant patients over eight years, from 2011-2019, at the oldest dedicated cardiovascular center, Shahid Rajaee Hospital (Tehran, Iran). The primary evaluated clinical outcomes were rejection, readmission, and mortality one month and one year after transplantation. For data analysis, univariate logistic regression analyses were conducted. Results: In this study, 107 patients (43.2%) were adults, and 132 patients (56.8%) were children. Notably, reoperation due to bleeding was a significant predictor of one-month mortality in both children (OR=7.47, P=0.006) and adults (OR=172.12, P<0.001). Moreover, the need for defibrillation significantly increased the risk of one-month mortality in both groups (children: OR=38.00, P<0.001; adults: OR=172.12, P<0.001). Interestingly, readmission had a protective effect against onemonth mortality in both children (OR=0.02, P<0.001) and adults (OR=0.004, P<0.001). Regarding one-year mortality, the use of extracorporeal membrane oxygenation (ECMO) was associated with a higher risk in both children (OR=7.64, P=0.001) and adults (OR=12.10, P<0.001). For children, reoperation due to postoperative hemorrhage also increased the risk (OR=5.14, P=0.020), while defibrillation was a significant risk factor in both children and adults (children: OR=22.00, P<0.001; adults: OR=172.12, P<0.001). The median post-surgery survival was 22 months for children and 24 months for adults. Conclusion: There was no correlation between sex and poorer outcomes. Mortality at one month and one year after transplantation was associated with the following risk factors: the use of ECMO, reoperation for bleeding, defibrillation following cross-clamp removal, and Intensive Care Unit (ICU) stay. Readmission, on the other hand, had a weak protective effect. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis.
- Author
-
Lanoiselée, Julien, Mourer, Jérémy, Jungling, Marie, Molliex, Serge, Thellier, Lise, Tabareau, Julien, Jeanpierre, Emmanuelle, Robin, Emmanuel, Susen, Sophie, Tavernier, Benoit, Vincentelli, André, Ollier, Edouard, and Moussa, Mouhamed Djahoum
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *HEPARIN , *CARDIOGENIC shock , *PHARMACOKINETICS , *C-reactive protein , *CLINICAL indications - Abstract
Background. Unfractionated heparin is administered in patients undergoing veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Anticoagulation monitoring is recommended, with an anti-activated factor X (anti-Xa) targeting 0.3 to 0.7 IU/mL. Owing to heparin's heterogeneous pharmacokinetic properties, anti-Xa is unpredictable, generating a challenge in anticoagulation practices. The aim of this study was to build a pharmacokinetic model of heparin accounting for potential confounders, and derive an optimized dosing regimen for a given anti-Xa target. Methods. Adult patients undergoing VA-ECMO were included between January 2020 and June 2021. Anticoagulation was managed with an initial 100 IU/kg heparin loading dose followed by a continuous infusion targeting 0.2 to 0.7 IU/mL anti-Xa. The data were split into model development and model validation cohorts. Statistical analysis was performed using a nonlinear mixed effects modeling population approach. Model-based simulations were performed to develop an optimized dosing regimen targeting the desired anti-Xa. Results. A total of 74 patients were included, with 1703 anti-Xa observations. A single-compartment model best fitted the data. Interpatient variability for distribution volume was best explained by body weight, C-reactive protein and ECMO indication (post-cardiotomy shock or medical cardiogenic shock), and interpatient variability for elimination clearance was best explained by serum creatinine and C-reactive protein. Simulations using the optimized regimen according to these covariates showed accurate anti-Xa target attainment. Conclusion. In adult patients on VA-ECMO, heparin's effect increased with serum creatinine and medical indication, whereas it decreased with body weight and systemic inflammation. We propose an optimized dosing regimen accounting for key covariates, capable of accurately predicting a given anti-Xa target. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center.
- Author
-
Hofstetter, Pia, Zuber-Jerger, Ina, Mehrl, Alexander, Graf, Bernhard, Lunz, Dirk, Lubnow, Matthias, Müller, Thomas, Schmid, Stephan, Müller, Martina, and Kandulski, Arne
- Subjects
- *
CHOLANGITIS , *COVID-19 , *INTRAHEPATIC bile ducts , *ADULT respiratory distress syndrome , *EXTRACORPOREAL membrane oxygenation , *ARTIFICIAL respiration - Abstract
Background & Aims: During the coronavirus disease 2019 (COVID-19) pandemic a significant proportion of patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection developed secondary sclerosing cholangitis (SSC) as a hepatobiliary complication. Methods: 17 patients were endoscopically diagnosed and treated with COVID-19 SSC from February 2020 until October 2022 at our center. We retrospectively reviewed and analyzed the data to define risk factors, establish endoscopic treatment options, and to estimate incidence and outcomes. Results: 258 patients with COVID-19 infection were admitted to our tertiary center and mechanically ventilated. 10 patients developed COVID-19 SSC in-house, and 7 patients were transferred for further endoscopic treatment. All 17 patients were mechanically ventilated, received vasoactive substances and 12 of them were treated with extracorporeal membrane oxygenation therapy. Endoscopic retrograde cholangiography (ERC) was performed in all patients to establish the diagnosis of COVID-19 SSC and evaluate endoscopic treatment options. All ERCs revealed biliary casts. 9 patients had developed severe rarefication of the intrahepatic bile ducts and 4 showed biliary strictures. As endoscopic treatment approaches, casts were removed repeatedly, and strictures were dilated. During the study period, 14 patients died (82%). 3 patients are in follow-up to reassess the need for liver transplantation. Conclusions: COVID-19 SSC was observed in 2.6 % of the patients with severe COVID-19 in our center. We show that endoscopic approaches offer the opportunity to extract casts and to treat biliary strictures. As the mortality rate of COVID-19 SSC is high, endoscopic treatment can be of great clinical relevance as a bridge to liver transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation.
- Author
-
Hong, Green, Kang, Da Hyun, Park, Sunghoon, Lee, Su Hwan, Park, Onyu, Kim, Taehwa, Yeo, Hye Ju, Jang, Jin Ho, Cho, Woo Hyun, and Lee, Song I
- Subjects
- *
COVID-19 , *OLDER patients , *ARTIFICIAL respiration , *EXTRACORPOREAL membrane oxygenation , *RENAL replacement therapy , *CORONAVIRUS diseases - Abstract
An older age is associated with severe progression and poor prognosis in coronavirus disease 2019 (COVID-19), and mechanical ventilation is often required. The specific characteristics of older patients undergoing mechanical ventilation and their prognostic factors are largely unknown. We aimed to identify potential prognostic factors in this group to inform treatment decisions. This retrospective cohort study collected data from patients with COVID-19 at 22 medical centers. Univariate and multivariate Cox regression analyses were performed to assess factors that influence mortality. We allocated 434 patients in geriatric (≥80 years) and elderly (65–79 years) groups. The former group scored significantly higher than the elderly group in the clinical frailty scale and sequential organ failure assessment, indicating more severe organ dysfunction. Significantly lower administration rates of tocilizumab and extracorporeal membrane oxygenation and higher intensive care unit (ICU) and in-hospital mortality were noted in the geriatric group. The factors associated with ICU and in-hospital mortality included high creatinine levels, the use of continuous renal replacement therapy, prone positioning, and the administration of life-sustaining treatments. These results highlight significant age-related differences in the management and prognosis of critically ill older patients with COVID-19. Increased mortality rates and organ dysfunction in geriatric patients undergoing mechanical ventilation necessitate age-appropriate treatment strategies to improve their prognoses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Comparing Outcomes of Post-Cardiotomy Cardiogenic Shock Patients: On-Site Cannulation vs. Retrieval for V-A ECMO Support.
- Author
-
Mihu, Mircea R., El Banayosy, Ahmed M., Harper, Michael D., Cain, Kaitlyn, Maybauer, Marc O., Swant, Laura V., Brewer, Joseph M., Schoaps, Robert S., Sharif, Ammar, Benson, Clayne, Freno, Daniel R., Bell, Marshall T., Chaffin, John, Elkins, Charles C., Vanhooser, David W., and El Banayosy, Aly
- Subjects
- *
CARDIOGENIC shock , *CORONARY artery bypass , *ARTIFICIAL blood circulation , *HEART assist devices , *EXTRACORPOREAL membrane oxygenation , *INTRA-aortic balloon counterpulsation - Abstract
Background: Post-cardiotomy cardiogenic shock (PCCS) remains a life-threatening complication after cardiac surgery. Extracorporeal membrane oxygenation (ECMO) represents the mainstay of mechanical circulatory support for PCCS; however, its availability is limited to larger experienced centers, leading to a mismatch between centers performing cardiac surgery and hospitals offering ECMO management beyond cannulation. We sought to evaluate the outcomes and complications of PCCS patients requiring veno-arterial (V-A) ECMO cannulated at our hospital compared to those cannulated at referral hospitals. Methods: A retrospective analysis of PCCS patients requiring V-A ECMO was conducted between October 2014 to December 2022. Results: A total of 121 PCCS patients required V-A ECMO support, of which 62 (51%) patients were cannulated at the referring institutions and retrieved (retrieved group), and 59 (49%) were cannulated at our hospital (on-site group). The baseline demographics and pre-ECMO variables were similar between groups, except retrieved patients had higher lactic acid levels (retrieved group: 8.5 mmol/L ± 5.8 vs. on-site group: 6.6 ± 5; p = 0.04). Coronary artery bypass graft was the most common surgical intervention (51% in the retrieved group vs. 47% in the on-site group). There was no difference in survival-to-discharge rates between the groups (45% in the retrieved group vs. 51% in the on-site group; p = 0.53) or in the rate of patient-related complications. Conclusions: PCCS patients retrieved on V-A ECMO can achieve similar outcomes as those cannulated at experienced centers. An established network in a hub-and-spoke model is critical for the PCCS patients managed at hospitals without ECMO abilities to improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. The impact of hypovolemia and PEEP on recirculation in venovenous ECMO: an experimental porcine model.
- Author
-
Antonsen, Lars Prag, Espinoza, Andreas, Halvorsen, Per Steinar, Schalit, Itai, Bergan, Harald, Lilja, Didrik, and Landsverk, Svein Aslak
- Abstract
Background: Recirculation is a common problem in venovenous extracorporeal membrane oxygenation (VV ECMO) and may limit the effect of ECMO treatment due to less efficient blood oxygenation or unfavorable ECMO and ventilator settings. The impact of hypovolemia and positive end expiratory pressure (PEEP) on recirculation is unclear and poorly described in guidelines, despite clinical importance. The aim of this study was to investigate how hypovolemia, autotransfusion and PEEP affect recirculation in comparison to ECMO cannula distance and circuit flow. Methods: In anesthetized and mechanically ventilated pigs (n = 6) on VV ECMO, we measured recirculation fraction (RF), changes in recirculation fraction (∆RF), hemodynamics and ECMO circuit pressures during alterations in PEEP (5 cmH2O vs 15 cmH2O), ECMO flow (3.5 L/min vs 5.0 L/min), cannula distance (10–14 cm vs 20–26 cm intravascular distance), hypovolemia (1000 mL blood loss) and autotransfusion (1000 mL blood transfusion). Results: Recirculation increased during hypovolemia (median ∆RF 43%), high PEEP (∆RF 28% and 12% with long and short cannula distance, respectively), high ECMO flow (∆RF 49% and 28% with long and short cannula distance, respectively) and with short cannula distance (∆RF 16%). Recirculation decreased after autotransfusion (∆RF − 45%). Conclusions: In the present animal study, hypovolemia, PEEP and autotransfusion were important determinants of recirculation. The alterations were comparable to other well-known factors, such as ECMO circuit flow and intravascular cannula distance. Interestingly, hypovolemia increased recirculation without significant change in ECMO drainage pressure, whereas high PEEP increased recirculation with less negative ECMO drainage pressure. Autotransfusion decreased recirculation. The findings are interesting for clinical studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. "Decompression illness" on extracorporeal membrane oxygenation.
- Author
-
Hu, Jiannan, zhao, Huijing, Bian, BingBing, San, Renfei, Yang, Peng, and Jiang, Yongpo
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *CARDIAC arrest , *DECOMPRESSION sickness , *CRITICALLY ill - Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is increasingly being used for critically ill patients with cardiopulmonary failure. Air in the ECMO circuit is an emergency, a rare but fatal complication. Case presentation: We introduce a case of a 76-year-old female who suffered from cardiac arrest complicated with severe trauma and was administered veno-arterial extracorporeal membrane oxygenation. In managing the patient with ECMO, air entered the ECMO circuit, which had not come out nor was folded or broken. Although the ECMO flow was quickly re-established, the patient died 6 h after initiating ECMO therapy. Conclusions: In this case report, the reason for the complication is drainage insufficiency. This phenomenon is similar to decompression sickness. Understanding this complication is very helpful for educating the ECMO team for preventing this rare but devastating complication of fatal decompression sickness in patients on ECMO. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Design and implementation of cardiac rehabilitation in pediatric heart re-transplantation: a case report.
- Author
-
da Silva Teixeira, Roberta and Martins da Silva, Fellipe Allevato
- Subjects
CARDIAC rehabilitation ,HEART transplantation ,EXTRACORPOREAL membrane oxygenation ,HEMORRHAGE ,PHYSICAL therapy - Abstract
Objective: There are no guidelines for cardiac rehabilitation in pediatric cardiac re-transplantation. The study describes the design and implementation of the exercise prescription in a cardiac rehabilitation program, which evaluated the indicators of respiratory muscle force, vital capacity, functional capacity, pulmonary function efficacy, manual muscle force, mobility, and generic health status in a 14-year-old male patient who underwent a heart re-transplant requiring extracorporeal membrane oxygenation. Case presentation: A 14-year old boy with redo heart transplantation was referred for rehabilitation. A heart transplant patient had an unfavorable evolution after pericardiectomy. He underwent re-transplantation and had extracorporeal membrane oxygenation dependence due to significant ventricular dysfunction. Diffuse alveolar hemorrhage and lower airways infectious/inflammatory process occurred during the days of mechanical ventilation. The physiotherapy team conducted the exercise prescription in a cardiac rehabilitation program and intervened during the hospital stay. The program included aerobic and resistance training, respiratory muscle strengthening and inspiratory capacity work, impairment-based interventions, non-invasive ventilatory support, and postural interventions. Quantitative assessments were applied weekly. Conclusion: Cardiac rehabilitation of the pediatric re-transplant patient was well succeeded. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Quantifying potential fluid transfused through pressure monitoring and circuit flushes in pediatric ECMO patients.
- Author
-
Robertson, Steven and White, Katherine
- Subjects
PRESSURE transducers ,EXTRACORPOREAL membrane oxygenation ,BLOOD volume ,VENOUS pressure ,FLUIDS - Abstract
Pressure monitoring on pediatric Extracorporeal Membrane Oxygenation (ECMO) circuits is used to aid in the evaluation of patient hemodynamics and circuit health. Extracorporeal Life Support Organization (ELSO) recommends monitoring pressures on the venous line, pre-, and post-oxygenator. In order to keep pressure ports patent, crystalloid can be used as a flush. The fluid transfused to the patient through these lines can be challenging to quantify accurately due to variance in clinician practice. Currently, there is no published data or practice suggestions on this topic. In Vitro experiments using Edwards True Wave transducers and pressure bags were constructed, allowing for common negative and positive pressures to be simulated. Passive volume infused through the transducer as well as intermittent active flushing by pulling the snap tab were measured and the volumes were recorded. When the pressure transducer and associated tubing are kept patent by using a pressurized IV bag, per the instructions for use, the daily volume transfused was found to be 319.6 mL or close to a typical neonate's total blood volume. Rather than using passive or active flushing, the use of automated syringe pumps can reduce the transfused volume to 24 mL per day. Further study is recommended to develop and publish best practices. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience.
- Author
-
Balder, Jan-Willem, Szymanski, Mariusz K., van Laake, Linda W., van der Harst, Pim, Meuwese, Christiaan L., Ramjankhan, Faiz Z., van der Meer, Manon G., Hermens, Jeannine A. J. M., Voskuil, Michiel, de Waal, Eric E. C., Donker, Dirk W., Oerlemans, Marish I. F. J., and Kraaijeveld, Adriaan O.
- Subjects
CARDIOGENIC shock ,HEART assist devices ,EXTRACORPOREAL membrane oxygenation ,ACUTE coronary syndrome ,HEART failure - Abstract
Background: In refractory cardiogenic shock, temporary mechanical support (tMCS) may be crucial for maintaining tissue perfusion and oxygen delivery. tMCS can serve as a bridge-to-decision to assess eligibility for left ventricular assist device (LVAD) implantation or heart transplantation, or as a bridge-to-recovery. ECPELLA is a novel tMCS configuration combining venoarterial extracorporeal membrane oxygenation with Impella. The present study presents the clinical parameters, outcomes, and complications of patients supported with ECPELLA. Methods: All patients supported with ECPELLA at University Medical Centre Utrecht between December 2020 and August 2023 were included. The primary outcome was 30-day mortality, and secondary outcomes were LVAD implantation/heart transplantation and safety outcomes. Results: Twenty patients with an average age of 51 years, and of whom 70% were males, were included. Causes of cardiogenic shock were acute heart failure (due to acute coronary syndrome, myocarditis, or after cardiac surgery) or chronic heart failure, respectively 70 and 30% of cases. The median duration of ECPELLA support was 164 h (interquartile range 98–210). In 50% of cases, a permanent LVAD was implanted. Cardiac recovery within 30 days was seen in 30% of cases and 30-day mortality rate was 20%. ECPELLA support was associated with major bleeding (40%), haemolysis (25%), vascular complications (30%), kidney failure requiring replacement therapy (50%), and Impella failure requiring extraction (15%). Conclusion: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Critical Hemorrhage Caused by a Size-Mismatched Extracorporeal Membrane Oxygenation Cannula in a Patient with Myotonic Dystrophy Type 1: A Case Report and Literature Review.
- Author
-
Shin, Changsik, Yoo, Kwon Cheol, and Kim, Dae Hoon
- Subjects
LITERATURE reviews ,MYOTONIA atrophica ,EXTRACORPOREAL membrane oxygenation ,CATHETERS ,VASCULAR closure devices ,FEMORAL artery ,CORNEAL dystrophies - Abstract
Background and Objective: Although extracorporeal membrane oxygenation (ECMO) is an essential life-saving technique for patients with refractory cardiopulmonary shock, it can be fatal in certain cases. Case Presentation: A 19-year-old girl treated with ECMO presented with acute limb ischemia 2 days after cannula removal. The decannulation was performed percutaneously by an interventional cardiologist, and the vascular surgery department was consulted after the patient developed symptoms. The first suspected diagnosis was thrombosis due to incorrect use of the closure device. However, the artery had ruptured due to the insertion of a catheter with a cannula that was larger than the patient's artery. Management and Outcome: Fortunately, excessive bleeding due to the size-mismatched cannula was prevented by an unintentional complication of the closing device, which saved the patient's life. She underwent a right common femoral artery thrombectomy and patch angioplasty. Hospital guidelines have changed regarding the surgical removal of ECMO cannulas. Discussion: This report aims to highlight the importance of two aspects that are critical to a successful outcome: individualized cannula selection followed by precise insertion and removal and postoperative evaluation of a patient's final status. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Extracorporeal Life Support in Myocardial Infarction: New Highlights.
- Author
-
Piccone, Giulia, Schiavoni, Lorenzo, Mattei, Alessia, and Benedetto, Maria
- Subjects
EXTRACORPOREAL membrane oxygenation ,MYOCARDIAL infarction ,ARTIFICIAL blood circulation ,CARDIOGENIC shock ,CONSERVATIVE treatment ,INTRA-aortic balloon counterpulsation - Abstract
Background and Objectives: Cardiogenic shock (CS) is a potentially severe complication following acute myocardial infarction (AMI). The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in these patients has risen significantly over the past two decades, especially when conventional treatments fail. Our aim is to provide an overview of the role of VA-ECMO in CS complicating AMI, with the most recent literature highlights. Materials and Methods: We have reviewed the current VA-ECMO practices with a particular focus on CS complicating AMI. The largest studies reporting the most significant results, i.e., overall clinical outcomes and management of the weaning process, were identified in the PubMed database from 2019 to 2024. Results: The literature about the use of VA-ECMO in CS complicating AMI primarily has consisted of observational studies until 2019, generating the need for randomized controlled trials. The EURO-SHOCK trial showed a lower 30-day all-cause mortality rate in patients receiving VA-ECMO compared to those receiving standard therapy. The ECMO-CS trial compared immediate VA-ECMO implementation with early conservative therapy, with a similar mortality rate between the two groups. The ECLS-SHOCK trial, the largest randomized controlled trial in this field, found no significant difference in mortality at 30 days between the ECMO group and the control group. Recent studies suggest the potential benefits of combining left ventricular unloading devices with VA-ECMO, but they also highlight the increased complication rate, such as bleeding and vascular issues. The routine use of VA-ECMO in AMI complicated by CS cannot be universally supported due to limited evidence and associated risks. Ongoing trials like the Danger Shock, Anchor, and Recover IV trials aim to provide further insights into the management of AMI complicated by CS. Conclusions: Standardizing the timing and indications for initiating mechanical circulatory support (MCS) is crucial and should guide future trials. Multidisciplinary approaches tailored to individual patient needs are essential to minimize complications from unnecessary MCS device initiation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants.
- Author
-
Krishnan, Amit V., Freniere, Victoria, Sahni, Rakesh, Vargas Chaves, Diana P., Krishnan, Sankaran S., Savva, Dimitrios, and Krishnan, Usha S.
- Subjects
CRITICALLY ill ,PATIENTS ,PATIENT safety ,EXTRACORPOREAL membrane oxygenation ,PULMONARY hypertension ,SCIENTIFIC observation ,FISHER exact test ,ILOPROST ,TREATMENT effectiveness ,RETROSPECTIVE studies ,SEVERITY of illness index ,DESCRIPTIVE statistics ,CHI-squared test ,MANN Whitney U Test ,HEMODYNAMICS ,INHALATION administration ,MEDICAL records ,ACQUISITION of data ,ANALYSIS of variance ,FRIEDMAN test (Statistics) ,DATA analysis software ,DRUG tolerance ,CHILDREN - Abstract
This is a single-center retrospective study to assess the safety and tolerability of continuous inhaled iloprost use as rescue therapy for refractory pulmonary hypertension (PH) in critically ill neonates and infants. A retrospective chart review was performed on 58 infants and data were collected at baseline, 1, 6, 12, 24, 48 and 72 h of iloprost initiation. Primary outcomes were change in heart rate (HR), fraction of inspired oxygen (FiO
2 ), mean airway pressures (MAP), blood pressure (BP) and oxygenation index (OI). Secondary outcomes were need for extracorporeal membrane oxygenation (ECMO) and death. 51 patients treated for >6 h were analyzed in 2 age groups, neonate (≤28 days: n = 32) and infant (29–365 days: n = 19). FiO2 (p < 0.001) and OI (p = 0.01) decreased, while there were no significant changes in MAP, BP and HR. Of the fifteen patients placed on ECMO, seven were bridged off ECMO on iloprost and eight died. Twenty-four out of fifty-one patients (47%) recovered without requiring ECMO, while twelve (23%) died. Iloprost as add-on therapy for refractory PH in critically ill infants in the NICU has an acceptable tolerability and safety profile. Large prospective multicenter studies using iloprost in the neonatal ICU are necessary to validate these results. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
40. Meconium Aspiration Syndrome, Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia—A Recipe for Severe Pulmonary Hypertension?
- Author
-
Sankaran, Deepika, Li, Jessa Rose A., and Lakshminrusimha, Satyan
- Subjects
PULMONARY hypertension prevention ,HYPOTHERMIA ,VENTILATION ,CEREBRAL anoxia-ischemia ,CARDIOMYOPATHIES ,NITRIC oxide ,EXTRACORPOREAL membrane oxygenation ,VASODILATORS ,DEATH ,SODIUM bicarbonate ,OXIDATIVE stress ,MECONIUM aspiration syndrome ,SILDENAFIL ,ASPHYXIA neonatorum ,PULMONARY surfactant ,MILRINONE - Abstract
Hypoxic-ischemic encephalopathy (HIE) is the leading cause of mortality among term newborns globally. Infants born through meconium-stained amniotic fluid are at risk of developing meconium aspiration syndrome (MAS) and HIE. Simultaneous occurrence of MAS and HIE is a perilous combination for newborns due to the risk of persistent pulmonary hypertension of the newborn (PPHN). Moreover, therapeutic hypothermia (TH), which is the current standard of care for the management of HIE, may increase pulmonary vascular resistance (PVR) and worsen PPHN. Infants with MAS and HIE require close cardiorespiratory and hemodynamic monitoring for PPHN. Therapeutic strategies, including oxygen supplementation, ventilation, use of surfactant, inhaled nitric oxide and other pulmonary vasodilators, and systemic vasopressors, play a critical role in the management of PPHN in MAS, HIE, and TH. While TH reduces death or disability in infants with HIE, infants with MAS and HIE undergoing TH need close hemodynamic monitoring for PPHN. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Treatment of late left bronchopleural fistula after left pneumonectomy through right thoracic approach assisted by extracorporeal membrane oxygenation.
- Author
-
Li, Wenhao, Liu, Kejun, Liao, Xiaozu, Li, Binfei, Liang, Yi, and Huang, Weizhao
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *BRONCHIAL fistula , *PNEUMONECTOMY , *CONSERVATIVE treatment , *PULMONARY artery , *TREATMENT effectiveness - Abstract
Background: Bronchopleural fistula (BPF) is a rare but fatal complication after pneumonectomy. When a BPF occurs late (weeks to years postoperatively), direct resealing of the bronchial stump through the primary thoracic approach is challenging due to the risks of fibrothorax and injury to the pulmonary artery stump, and the surgical outcome is generally poor. Here, we report a case of late left BPF following left pneumonectomy successfully treated using a right thoracic approach assisted by extracorporeal membrane oxygenation (ECMO). Case presentation: We report the case of a 57-year-old male patient who underwent left lower and left upper lobectomy, respectively, for heterochronic double primary lung cancer. A left BPF was diagnosed at the 22nd month postoperatively, and conservative treatment was ineffective. Finally, the left BPF was cured by minimally invasive BPF closure surgery via the right thoracic approach with the support of veno-venous extracorporeal membrane oxygenation (VV-ECMO). Conclusions: Advanced BPF following left pneumonectomy can be achieved with an individualized treatment plan, and the right thoracic approach assisted by ECMO is a relatively simple and effective method, which could be considered as an additional treatment option for similar patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. A nomogram predicting pneumonia after cardiac surgery: a retrospective modeling study.
- Author
-
Wang, Kuo, Zhang, Hai-Tao, Fan, Fu-Dong, Pan, Jun, Pan, Tuo, and Wang, Dong-Jin
- Subjects
- *
CARDIAC surgery , *EXTRACORPOREAL membrane oxygenation , *NOMOGRAPHY (Mathematics) , *INTRA-aortic balloon counterpulsation , *RECEIVER operating characteristic curves , *ARM circumference - Abstract
Background: Postoperative pneumonia (POP) is the most prevalent of all nosocomial infections in patients who underwent cardiac surgery. The aim of this study was to identify independent risk factors for pneumonia after cardiac surgery, from which we constructed a nomogram for prediction. Methods: The clinical data of patients admitted to the Department of Cardiothoracic Surgery of Nanjing Drum Tower Hospital from October 2020 to September 2021 who underwent cardiac surgery were retrospectively analyzed, and the patients were divided into two groups according to whether they had POP: POP group (n=105) and non-POP group (n=1083). Preoperative, intraoperative, and postoperative indicators were collected and analyzed. Logistic regression was used to identify independent risk factors for POP in patients who underwent cardiac surgery. We constructed a nomogram based on these independent risk factors. Model discrimination was assessed via area under the receiver operating characteristic curve (AUC), and calibration was assessed via calibration plot. Results: A total of 105 events occurred in the 1188 cases. Age (>55 years) (OR: 1.83, P=0.0225), preoperative malnutrition (OR: 3.71, P<0.0001), diabetes mellitus(OR: 2.33, P=0.0036), CPB time (Cardiopulmonary Bypass Time) > 135 min (OR: 2.80, P<0.0001), moderate to severe ARDS (Acute Respiratory Distress Syndrome)(OR: 1.79, P=0.0148), use of ECMO or IABP or CRRT (ECMO: Extra Corporeal Membrane Oxygenation; IABP: Intra-Aortic Balloon Pump; CRRT: Continuous Renal Replacement Therapy)(OR: 2.60, P=0.0057) and MV(Mechanical Ventilation)> 20 hours (OR: 3.11, P<0.0001) were independent risk factors for POP. Based on those independent risk factors, we constructed a simple nomogram with an AUC of 0.82. Calibration plots showed good agreement between predicted probabilities and actual probabilities. Conclusion: We constructed a facile nomogram for predicting pneumonia after cardiac surgery with good discrimination and calibration. The model has excellent clinical applicability and can be used to identify and adjust modifiable risk factors to reduce the incidence of POP as well as patient mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study.
- Author
-
Chiba, Yuki, Goto, Kota, Suzuki, Misako, Horiuchi, Hisanori, and Hayakawa, Mineji
- Subjects
- *
RISK assessment , *EXTRACORPOREAL membrane oxygenation , *PATIENTS , *SCIENTIFIC observation , *HOSPITAL admission & discharge , *RETROSPECTIVE studies , *HOSPITAL emergency services , *DESCRIPTIVE statistics , *BYSTANDER CPR , *BLOOD coagulation factors , *WESTERN immunoblotting , *HEMOSTASIS , *CARDIAC arrest , *VON Willebrand disease , *VASCULAR diseases , *DISEASE risk factors - Abstract
Background: Von Willebrand factor (vWF) plays a crucial role in hemostasis, acting as a key factor for platelet adhesion/aggregation and as a transport protein for coagulation factor VIII. vWF is secreted as a giant multimer, and it undergoes shear stress-dependent cleavage by a specific metalloproteinase in plasma. Among vWF multimers, high-molecular-weight (large) multimers are essential for hemostasis. Acquired von Willebrand syndrome, linked to various conditions, is a hemostatic disorder due to reduced vWF activity. Extracorporeal membrane oxygenation (ECMO), utilized recently for out-of-hospital cardiac arrest patients, generates high shear stress inside the pump. This stress may induce a conformational change in vWF, enhancing cleavage by a specific metalloproteinase and thereby reducing vWF activity. However, no study has investigated the effects of ECMO on vWF-related factors in patients receiving or not receiving ECMO. This study aimed to elucidate the relationship between ECMO treatment and acquired von Willebrand syndrome-related factors in patients with out-of-hospital cardiac arrest. Methods: This study included patients with cardiogenic out-of-hospital cardiac arrest admitted to our hospital. The patients were categorized into two groups (ECMO and non-ECMO) based on the presence or absence of ECMO treatment. Plasma samples were collected from patients admitted to the emergency department (days 0–4). The vWF antigen (vWF: Ag), vWF ristocetin cofactor activity (vWF: RCo), and factor VIII activity were measured. Additionally, a large multimer of vWF was evaluated through vWF multimer analysis, utilizing western blotting to probe vWF under non-reducing conditions. Results: The ECMO and non-ECMO groups included 10 and 22 patients, respectively. The median ECMO treatment in the ECMO group was 64.6 h. No differences in vWF: Ag or factor VIII activity were observed between the two groups during the observation period. However, the ECMO group exhibited a decrease in large vWF multimers and vWF: RCo during ECMO. Strong correlations were observed between vWF: RCo and vWF: Ag in both groups, although the relationships were significantly different between the two groups. Conclusions: ECMO treatment in patients with out-of-hospital cardiac arrest resulted in the loss of large vWF multimers and decreased vWF activity. Hence, decreased vWF activity should be considered as a cause of bleeding during ECMO management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. A rare case of pheochromocytoma in a pregnant woman presenting with chest pain: extraordinary management.
- Author
-
Ge, Tao, Xie, Xiangrong, and Liu, Jichun
- Subjects
CHEST pain ,PREGNANT women ,PHEOCHROMOCYTOMA ,PAIN management ,SYMPTOMS ,AORTIC dissection - Abstract
Background: Pheochromocytoma is rare in pregnant women. It presents as diverse symptoms, including hypertension and sweating. The symptoms of pregnant women with pheochromocytoma and comorbid hypertension often mimic the clinical manifestations of preeclampsia, and these women are often misdiagnosed with preeclampsia. Case presentation: In this case, a pregnant woman presented with chest pain as the primary symptom, and a diagnosis of pheochromocytoma was considered after ruling out myocardial ischemia and aortic dissection with the relevant diagnostic tools. This patient then underwent successful surgical resection using a nontraditional management approach, which resulted in a positive clinical outcome. Conclusions: It is essential to consider pheochromocytoma as a potential cause of chest pain and myocardial infarction-like electrocardiographic changes in pregnant women, even if they do not have a history of hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Transarterial embolization to treat a massive hemothorax during mechanical circulatory support via puncturing of the extracorporeal membrane oxygenation circuit.
- Author
-
Tsushima, Ryota, Maruhashi, Takaaki, Kurihara, Yutaro, Hashikata, Takehiro, and Asari, Yasushi
- Subjects
ARTIFICIAL blood circulation ,CARDIOGENIC shock ,EXTRACORPOREAL membrane oxygenation ,MYOCARDIAL infarction ,INTERNAL thoracic artery ,BRACHIAL artery ,PATIENTS' rights - Abstract
Background: Current guidelines recommend the use of mechanical circulatory support (MCS) for patients with cardiogenic shock that is refractory to medical therapy. Bleeding is the most common complication of MCS. Transarterial embolization (TAE) is often performed to treat this complication, because it is a less invasive hemostatic procedure. However, the TAE option needs to be carefully considered during MCS, as the access route may be limited during MCS. Case presentation: A man in his 70 s was diagnosed with acute myocardial infarction and underwent percutaneous coronary intervention via venoarterial extracorporeal membrane oxygenation (VA-ECMO) and Impella. During treatment in the intensive care unit, he suffered damage to a branch of the internal thoracic artery during a cardiac drainage procedure, which was subsequently treated via emergency TAE. An ECMO return cannula and an Impella sheath were inserted into the patient's right and left femoral arteries, respectively. An approach from the left brachial artery was selected, and the left internal thoracic artery was embolized. Subsequently, the patient required re-intervention to treat re-bleeding from another artery. Because it was difficult to target the target artery from the brachial one, owing to interference from the Impella catheter, the ECMO circuit near the return cannula was punctured and a guiding sheath was inserted. The ECMO flow and the patient's blood pressure decreased following placement of this guiding sheath. We were thus able to maintain the patient's blood pressure by increasing the infusion fluids and Impella flow, and embolize the target artery using a gelatin sponge to achieve hemostasis. Conclusion: When TAE is difficult to perform during MCS using an approach from the upper extremities, a lower extremity approach with a sheath inserted into the ECMO circuit may represent a viable alternative. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Predictors associated with successful weaning of veno-venous extracorporeal membrane oxygenation and mortality in adult patients with severe acute lung failure: Protocol of a pooled data analysis of cohort studies.
- Author
-
Ning, Yaxin, He, Linya, Pan, Keqi, Zhang, Weiwen, Luo, Jian, Chen, Yan, Mei, Zubing, and Wang, Danqiong
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *LUNGS , *CLINICAL decision support systems , *COHORT analysis , *DATA analysis , *CRITICAL care medicine - Abstract
Background: Severe acute lung failure (ALF) often necessitates veno-venous extracorporeal membrane oxygenation (VV-ECMO), where identifying predictors of weaning success and mortality remains crucial yet challenging. The study aims to identify predictors of weaning success and mortality in adults undergoing VV-ECMO for severe ALF, a gap in current clinical knowledge. Methods and analysis: PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials will be searched for cohort studies examining the predictive factors of successful weaning and mortality in adult patients on VV-ECMO due to severe ALF. Risk of bias assessment will be conducted using the Newcastle-Ottawa scale for each included study. The primary outcomes will be successful weaning from VV-ECMO and all-cause mortality. Between-study heterogeneity will be evaluated using the I2 statistic. Sensitivity, subgroup, and meta-regression analyses will be performed to ascertain potential sources of heterogeneity and assess the robustness of our results. We will use the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) tool to recommend the level of evidence. Discussion: This study seeks to provide clinically significant insights into predictors for weaning and mortality during VV-ECMO treatment for ALF, aiming to support clinical decisions and potentially influence health policy, thereby improving patient outcomes. Ethics and dissemination: Given the absence of direct engagement with human subjects or access to personal medical records, ethical approval for this study is deemed unnecessary. The study findings will be shared at a scientific conference either at the global or national level. Alternatively, the results will be presented for publication in a rigorously peer-reviewed journal regarding critical care medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome.
- Author
-
Bruni, Andrea, Battaglia, Caterina, Bosco, Vincenzo, Pelaia, Corrado, Neri, Giuseppe, Biamonte, Eugenio, Manti, Francesco, Mollace, Annachiara, Boscolo, Annalisa, Morelli, Michele, Navalesi, Paolo, Laganà, Domenico, Garofalo, Eugenio, and Longhini, Federico
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *ADULT respiratory distress syndrome , *COVID-19 , *PLEURAL effusions , *SUBCUTANEOUS emphysema , *LENGTH of stay in hospitals , *INTENSIVE care units - Abstract
Background: Acute respiratory distress syndrome (ARDS) presents a significant challenge in critical care settings, characterized by compromised gas exchange, necessitating in the most severe cases interventions such as veno-venous extracorporeal membrane oxygenation (vv-ECMO) when conventional therapies fail. Critically ill ARDS patients on vv-ECMO may experience several complications. Limited data exist comparing complication rates between COVID-19 and non-COVID-19 ARDS patients undergoing vv-ECMO. This retrospective observational study aimed to assess and compare complications in these patient cohorts. Methods: We retrospectively analyzed the medical records of all patients receiving vv-ECMO for ARDS between March 2020 and March 2022. We recorded the baseline characteristics, the disease course and complication (barotrauma, bleeding, thrombosis) before and after ECMO cannulation, and clinical outcomes (mechanical ventilation and ECMO duration, intensive care unit, and hospital lengths of stay and mortalities). Data were compared between COVID-19 and non-COVID-19 patients. In addition, we compared survived and deceased patients. Results: Sixty-four patients were included. COVID-19 patients (n = 25) showed higher rates of pneumothorax (28% vs. 8%, p = 0.039) with subcutaneous emphysema (24% vs. 5%, p = 0.048) and longer non-invasive ventilation duration before vv-ECMO cannulation (2 [1; 4] vs. 0 [0; 1] days, p = <0.001), compared to non-COVID-19 patients (n = 39). However, complication rates and clinical outcomes post-vv-ECMO were similar between groups. Survival analysis revealed no significant differences in pre-vv-ECMO complications, but non-surviving patients had a trend toward higher complication rates and more pleural effusions post-vv-ECMO. Conclusions: COVID-19 patients on vv-ECMO exhibit higher pneumothorax rates with subcutaneous emphysema pre-cannulation; post-cannulation complications are comparable to non-COVID-19 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Mechanisms maintaining right ventricular contractility-to-pulmonary arterial elastance ratio in VA ECMO: a retrospective animal data analysis of RV–PA coupling.
- Author
-
Bachmann, Kaspar F., Moller, Per Werner, Hunziker, Lukas, Maggiorini, Marco, and Berger, David
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *DATA analysis , *PULMONARY embolism , *PULMONARY artery , *VENTRICULAR remodeling - Abstract
Background: To optimize right ventricular–pulmonary coupling during veno-arterial (VA) ECMO weaning, inotropes, vasopressors and/or vasodilators are used to change right ventricular (RV) function (contractility) and pulmonary artery (PA) elastance (afterload). RV–PA coupling is the ratio between right ventricular contractility and pulmonary vascular elastance and as such, is a measure of optimized crosstalk between ventricle and vasculature. Little is known about the physiology of RV–PA coupling during VA ECMO. This study describes adaptive mechanisms for maintaining RV–PA coupling resulting from changing pre- and afterload conditions in VA ECMO. Methods: In 13 pigs, extracorporeal flow was reduced from 4 to 1 L/min at baseline and increased afterload (pulmonary embolism and hypoxic vasoconstriction). Pressure and flow signals estimated right ventricular end-systolic elastance and pulmonary arterial elastance. Linear mixed-effect models estimated the association between conditions and elastance. Results: At no extracorporeal flow, end-systolic elastance increased from 0.83 [0.66 to 1.00] mmHg/mL at baseline by 0.44 [0.29 to 0.59] mmHg/mL with pulmonary embolism and by 1.36 [1.21 to 1.51] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Pulmonary arterial elastance increased from 0.39 [0.30 to 0.49] mmHg/mL at baseline by 0.36 [0.27 to 0.44] mmHg/mL with pulmonary embolism and by 0.75 [0.67 to 0.84] mmHg/mL with hypoxic pulmonary vasoconstriction (p < 0.001). Coupling remained unchanged (2.1 [1.8 to 2.3] mmHg/mL at baseline; − 0.1 [− 0.3 to 0.1] mmHg/mL increase with pulmonary embolism; − 0.2 [− 0.4 to 0.0] mmHg/mL with hypoxic pulmonary vasoconstriction, p > 0.05). Extracorporeal flow did not change coupling (0.0 [− 0.0 to 0.1] per change of 1 L/min, p > 0.05). End-diastolic volume increased with decreasing extracorporeal flow (7.2 [6.6 to 7.8] ml change per 1 L/min, p < 0.001). Conclusions: The right ventricle dilates with increased preload and increases its contractility in response to afterload changes to maintain ventricular–arterial coupling during VA extracorporeal membrane oxygenation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Exploratory factor analysis yields grouping of brain injury biomarkers significantly associated with outcomes in neonatal and pediatric ECMO.
- Author
-
Huang, Victoria, Roem, Jennifer, Ng, Derek K., McElrath Schwartz, Jamie, Everett, Allen D., Padmanabhan, Nikhil, Romero, Daniel, Joe, Jessica, Campbell, Christopher, Sigal, George B., Wohlstadter, Jacob N., and Bembea, Melania M.
- Subjects
- *
BRAIN injuries , *BIOMARKERS , *EXPLORATORY factor analysis , *MULTIVARIABLE testing , *HOSPITAL mortality - Abstract
In this two-center prospective cohort study of children on ECMO, we assessed a panel of plasma brain injury biomarkers using exploratory factor analysis (EFA) to evaluate their interplay and association with outcomes. Biomarker concentrations were measured daily for the first 3 days of ECMO support in 95 participants. Unfavorable composite outcome was defined as in-hospital mortality or discharge Pediatric Cerebral Performance Category > 2 with decline ≥ 1 point from baseline. EFA grouped 11 biomarkers into three factors. Factor 1 comprised markers of cellular brain injury (NSE, BDNF, GFAP, S100β, MCP1, VILIP-1, neurogranin); Factor 2 comprised markers related to vascular processes (vWF, PDGFRβ, NPTX1); and Factor 3 comprised the BDNF/MMP-9 cellular pathway. Multivariable logistic models demonstrated that higher Factor 1 and 2 scores were associated with higher odds of unfavorable outcome (adjusted OR 2.88 [1.61, 5.66] and 1.89 [1.12, 3.43], respectively). Conversely, higher Factor 3 scores were associated with lower odds of unfavorable outcome (adjusted OR 0.54 [0.31, 0.88]), which is biologically plausible given the role of BDNF in neuroplasticity. Application of EFA on plasma brain injury biomarkers in children on ECMO yielded grouping of biomarkers into three factors that were significantly associated with unfavorable outcome, suggesting future potential as prognostic instruments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Organ donation after extracorporeal cardiopulmonary resuscitation: a nationwide retrospective cohort study.
- Author
-
Yumoto, Tetsuya, Tsukahara, Kohei, Obara, Takafumi, Hongo, Takashi, Nojima, Tsuyoshi, Naito, Hiromichi, and Nakao, Atsunori
- Abstract
Background: Limited data are available on organ donation practices and recipient outcomes, particularly when comparing donors who experienced cardiac arrest and received extracorporeal cardiopulmonary resuscitation (ECPR) followed by veno-arterial extracorporeal membrane oxygenation (ECMO) decannulation, versus those who experienced cardiac arrest without receiving ECPR. This study aims to explore organ donation practices and outcomes post-ECPR to enhance our understanding of the donation potential after cardiac arrest. Methods: We conducted a nationwide retrospective cohort study using data from the Japan Organ Transplant Network database, covering all deceased organ donors between July 17, 2010, and August 31, 2022. We included donors who experienced at least one episode of cardiac arrest. During the study period, patients undergoing ECMO treatment were not eligible for a legal diagnosis of brain death. We compared the timeframes associated with each donor's management and the long-term graft outcomes of recipients between ECPR and non-ECPR groups. Results: Among 370 brain death donors with an episode of cardiac arrest, 26 (7.0%) received ECPR and 344 (93.0%) did not; the majority were due to out-of-hospital cardiac arrests. The median duration of veno-arterial ECMO support after ECPR was 3 days. Patients in the ECPR group had significantly longer intervals from admission to organ procurement compared to those not receiving ECPR (13 vs. 9 days, P = 0.005). Lung graft survival rates were significantly lower in the ECPR group (log-rank test P = 0.009), with no significant differences in other organ graft survival rates. Of 160 circulatory death donors with an episode of cardiac arrest, 27 (16.9%) received ECPR and 133 (83.1%) did not. Time intervals from admission to organ procurement following circulatory death and graft survival showed no significant differences between ECPR and non-ECPR groups. The number of organs donated was similar between the ECPR and non-ECPR groups, regardless of brain or circulatory death. Conclusions: This nationwide study reveals that lung graft survival was lower in recipients from ECPR-treated donors, highlighting the need for targeted research and protocol adjustments in post-ECPR organ donation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.